Pan-immune-inflammation value is associated with poor prognosis in patients undergoing peritoneal dialysis.

导出 OA

翻译打印收藏纠错

作者： Fengping,Zhang ^[1] ; Luohua,Li ^[1] ; Xianfeng,Wu ^[2] ; Yueqiang,Wen ^[3] ; Xiaojiang,Zhan ^[4] ; Fenfen,Peng ^[5] ; Xiaoyang,Wang ^[6] ; Qian,Zhou ^[7] ; Xiaoran,Feng ^[1]

作者单位： Department of Nephrology, Jiujiang No. 1 People's Hospital, Jiujiang, China. ^[1] Department of Nephrology, Affiliated Sixth People's Hospital, Shanghai, China. ^[2] Department of Nephrology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China. ^[3] Department of Nephrology, The First Affiliated Hospital of Nanchang University, Nanchang, China. ^[4] Department of Nephrology, Zhujiang Hospital of Southern Medical University, Guangzhou, China. ^[5] Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. ^[6] Department of Medical Statistics, Clinical Trials Unit, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China. ^[7]

关键词 Peritoneal dialysis biomarker pan-immune-inflammation value prognosis

主题词人类(Humans);回顾性研究(Retrospective Studies);腹膜透析(Peritoneal Dialysis);预后(Prognosis);炎症(Inflammation);心血管疾病(Cardiovascular Diseases);比例危险度模型(Proportional Hazards Models)

DOI 10.1080/0886022X.2022.2158103

PMID 36632816

发布时间 2023-01-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交